Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 1048-1053

  Qari, S H ^a   Magre, S ^a   Garcia Lerma J G ^a   Hussain, A I ^a   Takeuchi, Y ^a   Patience, C ^a   Weiss, R A ^a   Heneine, W ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ANIMAL CELL; ARTICLE; DRUG SENSITIVITY; GENETIC MANIPULATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEINASE INHIBITION; SWINE; VIRUS PARTICLE; VIRUS TRANSMISSION; XENOGRAFT; XENOTRANSPLANTATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENDOGENOUS RETROVIRUSES; ENDOPEPTIDASES; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; RNA-DIRECTED DNA POLYMERASE; SWINE; VIRUS CULTIVATION;

EID: 0035167985     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.1048-1053.2001     Document Type: Article

References (54)

1. Identification of a full-length cDNA for an endogenous retrovirus of miniature swine
2. Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture
3. Resistance to human immunodeficiency virus type 1 protease inhibitors
4. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency
5. Treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation
6. Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials
7. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus
8. Retroviridae: The viruses and their replication
9. Antiviral properties of Ro 31-8959, an inhibitor of human immunodeficiency virus (HIV) proteinase
10. The use of xenografts for acute hepatic failure
11. Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease
12. HIV protease as a target for the design of antiviral agents for AIDS
13. Retroviral-mediated gene transfer into hepatocytes in vivo
14. Pharmacology of antiretroviral agents
15. A rapid non-culture-based assay for clinical monitoring of phenotypic resistance of human immunodeficiency virus type 1 to lamivudine (3TC)
16. Generation of human monoclonal antibodies to human immunodeficiency virus
17. Transplantation of porcine fetal pancreas to diabetic patients
18. Postexposure chemoprophylaxis for occupational exposures to the human immunodeficiency virus
19. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts
20. Detection of reverse transcriptase by a highly sensitive assay in sera from persons infected with human immunodeficiency virus type 1
21. Crystal structure at 3.5 Å resolution of HIV-1 reverse transcriptase complexed with an inhibitor
22. Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice
23. Two sets of human-tropic pig retroviruses
24. Liver allotransplantation after extracorporeal hepatic support with transgenic (hCD55/hCD59) porcine livers: Clinical results and lack of pig-to-human transmission of the porcine endogenous retrovirus
25. AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro
26. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells
27. Development and validation of a Western immunoblot assay for detection of antibodies to porcine endogenous retrovirus
28. Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2′,3′-dideoxynucleosides in vitro
29. Kinetics of antiviral activity and intracellular pharmacokinetics of human immunodeficiency virus type 1 protease inhibitors in tissue culture
30. Resistance of human immunodeficiency virus type 1 to acyclic 6-phenylselenenyl- and 6-phenylthiopyrimidines
31. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue
32. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys
33. Infection of human cells by an endogenous retrovirus of pigs
34. HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells
35. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements
36. Comparison of efficiency of infection of gene therapy target cells via four different retroviral receptors
37. Efficacy of antiretroviral agents against murine replication-competent retrovirus infection in human cells
38. Selective inhibition of human immunodeficiency viruses by racemates and enantiomeres of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
39. A workbench for multiple alignment construction and analysis
40. Transplantation of embryonic porcine mesencephalic tissue in patients with PD
41. Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides
42. Cell to cell fusion, but not virus entry in macrophages by T-cell tropic HIV-1 strains: A V3 loop determined restriction
43. Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1
44. Host-range and interference studies on three classes of pig endogenous retrovirus
45. Type C retroviral inactivation by human complement is determined by both the viral genome and the producer cell
46. Retroviral pseudotypes produced by rescue of a Moloney murine leukemia virus vector by C-type, but not D-type, retroviruses
47. 3′-Azido-3′-deoxythymidine in feline leukemia virus-infected cats: A model for therapy and prophylaxis of AIDS
48. Pig-to-human islet transplantation in eight patients
49. Enzymatic characterization of human immunodeficiency virus type-1 reverse transcriptase resistant to multiple 2′,3′-dideoxynucleoside 5′-triphosphates
50. Rapid screening of phenotypic resistance to nevirapine by direct analysis of HIV type 1 reverse transcriptase activity in plasma
51. Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells
52. Extended analysis of the in vitro tropism of porcine endogenous retrovirus
53. Highly sensitive qualitative and quantitative detection of reverse transcriptase activity: Optimization, validation, and comparative analysis with other detection systems
54. Mother-to-child HIV-1 transmission: State of the art and implications for public policy